Activating CBL mutations are associated with a distinct MDS/MPN phenotype
Activating point mutations in CBL have recently been identified in diverse subtypes of myeloid neoplasms. Because detailed clinical and hematological characteristics of CBL-mutated cases is lacking, we screened 156 BCR-ABL and JAK2 V617F negative patients with myeloproliferative neoplasms (MPN) and...
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
10 August 2012
|
| In: |
Annals of hematology
Year: 2012, Jahrgang: 91, Heft: 11, Pages: 1713-1720 |
| ISSN: | 1432-0584 |
| DOI: | 10.1007/s00277-012-1521-3 |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.1007/s00277-012-1521-3 Verlag, Volltext: https://link.springer.com/article/10.1007/s00277-012-1521-3 
|
| Verfasserangaben: | Juliana Schwaab, Thomas Ernst, Philipp Erben, Jenny Rinke, Susanne Schnittger, Philipp Ströbel, Georgia Metzgeroth, Max Mossner, Torsten Haferlach, Nicholas C. P. Cross, Andreas Hochhaus, Wolf-Karsten Hofmann, Andreas Reiter |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1576203921 | ||
| 003 | DE-627 | ||
| 005 | 20220814160114.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180608s2012 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00277-012-1521-3 |2 doi | |
| 035 | |a (DE-627)1576203921 | ||
| 035 | |a (DE-576)506203921 | ||
| 035 | |a (DE-599)BSZ506203921 | ||
| 035 | |a (OCoLC)1341011339 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Schwaab, Juliana |d 1982- |e VerfasserIn |0 (DE-588)1051912687 |0 (DE-627)787019399 |0 (DE-576)407558764 |4 aut | |
| 245 | 1 | 0 | |a Activating CBL mutations are associated with a distinct MDS/MPN phenotype |c Juliana Schwaab, Thomas Ernst, Philipp Erben, Jenny Rinke, Susanne Schnittger, Philipp Ströbel, Georgia Metzgeroth, Max Mossner, Torsten Haferlach, Nicholas C. P. Cross, Andreas Hochhaus, Wolf-Karsten Hofmann, Andreas Reiter |
| 264 | 1 | |c 10 August 2012 | |
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 20.08.2020 | ||
| 520 | |a Activating point mutations in CBL have recently been identified in diverse subtypes of myeloid neoplasms. Because detailed clinical and hematological characteristics of CBL-mutated cases is lacking, we screened 156 BCR-ABL and JAK2 V617F negative patients with myeloproliferative neoplasms (MPN) and overlap syndromes between myelodysplastic syndrome (MDS) and MPN (MPS/MPN) for mutations in exons 8 and 9 of CBL by denaturing high-performance liquid chromatography and direct sequencing. CBL mutations were identified in 16/156 patients (10 %), of which five also carried mutations in EZH2 (n = 3) and TET2 (n = 2). Comprehensive clinical and hematological characteristics were available from 13/16 patients (81 %). In addition to splenomegaly (77 %), striking common hematological features were CML-like left-shifted leukocytosis (85 %) with monocytosis (85 %), anemia (100 %), and thrombocytopenia (62 %). Thrombocytosis was not observed in any patient. Relevant bone marrow features (n = 12) included hypercellularity (92 %) with marked granulopoiesis (92 %), nonclustered microlobulated megakaryocytes (83 %), and marrow fibrosis (83 %). Nine deaths (progression to secondary acute myeloid leukemia/blast phase, n = 7; cytopenia complications, n = 2) were recorded. Three-year survival rate was 27 %, possibly indicating poor prognosis of CBL mutated MDS/MPN patients. | ||
| 700 | 1 | |a Erben, Philipp |d 1973- |e VerfasserIn |0 (DE-588)128501014 |0 (DE-627)373920997 |0 (DE-576)297181661 |4 aut | |
| 700 | 1 | |a Ströbel, Philipp |d 1969- |e VerfasserIn |0 (DE-588)115588272 |0 (DE-627)077346734 |0 (DE-576)289964784 |4 aut | |
| 700 | 1 | |a Metzgeroth, Georgia |d 1972- |e VerfasserIn |0 (DE-588)1051897661 |0 (DE-627)786986832 |0 (DE-576)407534075 |4 aut | |
| 700 | 1 | |a Mossner, Maximilian |d 1984- |e VerfasserIn |0 (DE-588)1033912379 |0 (DE-627)745111572 |0 (DE-576)381596222 |4 aut | |
| 700 | 1 | |a Hofmann, Wolf-Karsten |d 1967- |e VerfasserIn |0 (DE-588)114154635 |0 (DE-627)691208751 |0 (DE-576)351568336 |4 aut | |
| 700 | 1 | |a Reiter, Andreas |d 1964- |e VerfasserIn |0 (DE-588)172629551 |0 (DE-627)697563766 |0 (DE-576)133488594 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of hematology |d Berlin : Springer, 1991 |g 91(2012), 11, Seite 1713-1720 |h Online-Ressource |w (DE-627)253389852 |w (DE-600)1458429-3 |w (DE-576)072283157 |x 1432-0584 |7 nnas |a Activating CBL mutations are associated with a distinct MDS/MPN phenotype |
| 773 | 1 | 8 | |g volume:91 |g year:2012 |g number:11 |g pages:1713-1720 |g extent:8 |a Activating CBL mutations are associated with a distinct MDS/MPN phenotype |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00277-012-1521-3 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://link.springer.com/article/10.1007/s00277-012-1521-3 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20180608 | ||
| 993 | |a Article | ||
| 994 | |a 2012 | ||
| 998 | |g 172629551 |a Reiter, Andreas |m 172629551:Reiter, Andreas |d 60000 |d 61200 |e 60000PR172629551 |e 61200PR172629551 |k 0/60000/ |k 1/60000/61200/ |p 13 |y j | ||
| 998 | |g 114154635 |a Hofmann, Wolf-Karsten |m 114154635:Hofmann, Wolf-Karsten |d 60000 |d 61200 |e 60000PH114154635 |e 61200PH114154635 |k 0/60000/ |k 1/60000/61200/ |p 12 | ||
| 998 | |g 1033912379 |a Mossner, Maximilian |m 1033912379:Mossner, Maximilian |d 60000 |d 61200 |e 60000PM1033912379 |e 61200PM1033912379 |k 0/60000/ |k 1/60000/61200/ |p 8 | ||
| 998 | |g 1051897661 |a Metzgeroth, Georgia |m 1051897661:Metzgeroth, Georgia |d 60000 |d 61200 |e 60000PM1051897661 |e 61200PM1051897661 |k 0/60000/ |k 1/60000/61200/ |p 7 | ||
| 998 | |g 115588272 |a Ströbel, Philipp |m 115588272:Ströbel, Philipp |p 6 | ||
| 998 | |g 128501014 |a Erben, Philipp |m 128501014:Erben, Philipp |d 60000 |d 61200 |e 60000PE128501014 |e 61200PE128501014 |k 0/60000/ |k 1/60000/61200/ |p 3 | ||
| 998 | |g 1051912687 |a Schwaab, Juliana |m 1051912687:Schwaab, Juliana |d 60000 |d 61200 |e 60000PS1051912687 |e 61200PS1051912687 |k 0/60000/ |k 1/60000/61200/ |p 1 |x j | ||
| 999 | |a KXP-PPN1576203921 |e 3012254064 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"title":[{"title_sort":"Activating CBL mutations are associated with a distinct MDS/MPN phenotype","title":"Activating CBL mutations are associated with a distinct MDS/MPN phenotype"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"person":[{"role":"aut","display":"Schwaab, Juliana","roleDisplay":"VerfasserIn","given":"Juliana","family":"Schwaab"},{"role":"aut","given":"Philipp","roleDisplay":"VerfasserIn","display":"Erben, Philipp","family":"Erben"},{"role":"aut","display":"Ströbel, Philipp","roleDisplay":"VerfasserIn","given":"Philipp","family":"Ströbel"},{"role":"aut","given":"Georgia","roleDisplay":"VerfasserIn","display":"Metzgeroth, Georgia","family":"Metzgeroth"},{"family":"Mossner","given":"Maximilian","roleDisplay":"VerfasserIn","display":"Mossner, Maximilian","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","given":"Wolf-Karsten","display":"Hofmann, Wolf-Karsten","family":"Hofmann"},{"role":"aut","family":"Reiter","given":"Andreas","roleDisplay":"VerfasserIn","display":"Reiter, Andreas"}],"name":{"displayForm":["Juliana Schwaab, Thomas Ernst, Philipp Erben, Jenny Rinke, Susanne Schnittger, Philipp Ströbel, Georgia Metzgeroth, Max Mossner, Torsten Haferlach, Nicholas C. P. Cross, Andreas Hochhaus, Wolf-Karsten Hofmann, Andreas Reiter"]},"id":{"doi":["10.1007/s00277-012-1521-3"],"eki":["1576203921"]},"recId":"1576203921","language":["eng"],"note":["Gesehen am 20.08.2020"],"relHost":[{"disp":"Activating CBL mutations are associated with a distinct MDS/MPN phenotypeAnnals of hematology","language":["eng"],"note":["Gesehen am 24.04.2025","Fortsetzung der Druck-Ausgabe","Ungezählte Beil. ab 80.2001: Supplement"],"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"dateIssuedDisp":"1991-","publisher":"Springer","publisherPlace":"Berlin ; Heidelberg ; New York","dateIssuedKey":"1991"}],"titleAlt":[{"title":"Hematology"}],"title":[{"title_sort":"Annals of hematology","subtitle":"organ of: Gesellschaft für Thrombose- und Hämostaseforschung, DGHO, Deutsche Gesellschaft für Hämatologie und Onkologie e.V., ÖGHO, Österreichische Gesellschaft für Hämatologie und Onkologie","title":"Annals of hematology"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"part":{"text":"91(2012), 11, Seite 1713-1720","extent":"8","volume":"91","pages":"1713-1720","year":"2012","issue":"11"},"pubHistory":["62, 1 (Februrary 1991)-"],"id":{"zdb":["1458429-3"],"eki":["253389852"],"issn":["1432-0584"]},"recId":"253389852"}],"physDesc":[{"extent":"8 S."}],"origin":[{"dateIssuedDisp":"10 August 2012","dateIssuedKey":"2012"}]} | ||
| SRT | |a SCHWAABJULACTIVATING1020 | ||